Loading...

BCAL Diagnostics Limited

BDX.AX•ASX
HealthcareMedical - Diagnostics & Research
$0.07
$-0.00(-1.33%)

BCAL Diagnostics Limited (BDX.AX) Stock Overview

Explore BCAL Diagnostics Limited’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
8.60%
↑ 8.60%
Profit Growth
$-0.02
↓ 26.44%
EPS Growth
$-0.02
↓ 8.33%
Operating Margin
-255.15%
↑ 31.03%
ROE
-89.51%
↓ 26.44%
Dividend Yield
0.00%
Analyst Recommendations data is not available for BDX.AXAnalyst Recommendations details for BDX.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from extracellular vesicles from a patient's plasma or blood sample to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.

CEO

Mr. Shane Ryan M.B.A.

Headquarters

50 Clarence Street, Sydney, NSW

Founded

2021

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal

Resources

Market

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.